MEETSIES SA
A stranger
DREAMS: Drug REpurposing with Artificial intelligence for Muscular disorderS
MEETSIES SA
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2022-DISEASE-06-two-stage
According to World Health Organization, to date, fewer than 6% of rare diseases (RDs) have an approved treatment option. In the light of thi...
2023-10-08 - 2028-10-31 | financed
2023-10-08 - 2028-10-31 | financed
* No data from the current company are not available.